Related Experiment Video
Updated: Jul 17, 2026
09:12
Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells
Published on: June 14, 2024
Tumor hypoxia and targeted gene therapy.
1Tumour Microcirculation Group, University of Sheffield, Royal Hallamshire Hospital, Sheffield, United Kingdom.
International Review of Cytology
|February 7, 2007
Summary
Targeting hypoxic tumor cells with gene therapy offers a promising strategy to overcome treatment resistance and improve patient survival. Innovations focus on selective gene delivery, expression regulation, and disrupting hypoxia-inducible factor signaling.
Area of Science:
- Oncology
- Molecular Biology
- Gene Therapy
Background:
- Hypoxia is a key feature of the tumor microenvironment, linked to poor outcomes in cancer treatment.
- Tumor hypoxia promotes resistance to radiotherapy, chemotherapy, and surgery, and drives metastasis.
- Targeting hypoxic cells is crucial for improving local tumor control and overall patient survival.
Purpose of the Study:
- To review recent advancements in gene therapy strategies specifically designed to target hypoxic tumor areas.
- To highlight innovative approaches for overcoming challenges in hypoxia-targeted gene therapy.
Main Methods:
- Discussion of gene therapy delivery methods that selectively reach hypoxic tumor regions.
- Exploration of gene expression regulation systems responsive to tumor hypoxia.
- Overview of therapeutic strategies aimed at disrupting hypoxia-inducible factor (HIF) signaling.
Main Results:
- Identification of hypoxia-conditionally replicating viruses as a promising delivery vector.
- Evaluation of cellular vehicles for targeted gene delivery to hypoxic tumors.
- Analysis of gene therapy approaches to inhibit HIF pathway activation.
Conclusions:
- Hypoxia-targeted gene therapy presents a significant opportunity to enhance cancer treatment efficacy.
- Novel strategies involving conditional viral replication, cellular transport, and HIF pathway modulation show potential.
- Further research in these areas could lead to improved therapeutic outcomes for cancer patients.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.